Digitally Assisted Recovery Coach

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05393544
Collaborator
(none)
10
1
1
6.4
1.6

Study Details

Study Description

Brief Summary

The aims of this proof-of-concept study are to determine the feasibility of 1) using a smartphone app ("Lifeguard") to facilitate engagement with a peer recovery coach, 2) monitoring post-detox using a modified Brief Addiction Monitor, and 3) assessing linkage to care post-detox.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digitally assisted peer recovery coach
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Digitally Assisted Virtual Recovery Coach to Improve Inpatient Alcohol Withdrawal Management: A Proof-of-concept Pilot Study
Actual Study Start Date :
Nov 1, 2021
Actual Primary Completion Date :
Apr 1, 2022
Actual Study Completion Date :
May 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

The intervention utilizes an existing care coordination smartphone app to allow participants to engage with a recovery coach during and after an inpatient admission to an inpatient withdrawal management facility (i.e. detox).

Behavioral: Digitally assisted peer recovery coach
The certified peer recovery coach utilized an existing care coordination smartphone app to provide support to the patient during and after an inpatient detoxification treatment for alcohol use disorder. The coach utilized the telephone or text messages to send daily motivational messages, remind about upcoming appointments, and checked-in if responses were concerning. Follow-up by the coach continued for 30 days.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of coach engagement [30 days]

    The proportion and the number of days of participants engaging with the coach during and after detoxification.

Secondary Outcome Measures

  1. Feasibility of monitoring clinical status [30 days]

    The proportion and the number of days of participants responding to prompts during and after detoxification.

  2. Linkage to care [30 days]

    The proportion of participants successfully linking to care after discharge.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults aged 18 to 65

  • Diagnosis of DSM-5 alcohol use disorder

  • Admitted to Brigham and Women's Faulkner Hospital (BWF) inpatient Addiction Recovery Program to treat alcohol withdrawal

  • Own either an iOS or Android smartphone device

  • Have an active email address

  • English speaking

Exclusion Criteria:
  • Inability to provide informed consent due to delirium or other cognitive impairments

  • Current psychosis, suicidality or homicidality

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brigham and Women's Faulkner Hospital Boston Massachusetts United States 02130

Sponsors and Collaborators

  • Brigham and Women's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joji Suzuki, MD, Director, Division of Addiction Psychiatry, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT05393544
Other Study ID Numbers:
  • 2021P000731
First Posted:
May 26, 2022
Last Update Posted:
May 26, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joji Suzuki, MD, Director, Division of Addiction Psychiatry, Brigham and Women's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 26, 2022